Efficacy of granulocyte-macrophage colony-stimulating factor in acquired alveolar proteinosis.

نویسندگان

  • J F Seymour
  • A R Dunn
  • J M Vincent
  • J J Presneill
  • M C Pain
چکیده

that both artemether and the closely related compound arteether induce a selective pattern of damage principally to the brain-stem nuclei involved in auditory processing. 3 If the prolongation of coma observed in our study and in the accompanying study from the Gambia was caused by neurotoxicity, then it was reversible. There was no associated neurologic deficit in survivors, and no evidence of auditory abnormalities. The incidence of neurologic sequelae in the Gambian trial was also similar in the two treatment groups. We believe that a definitive statement regarding the relative merits of artemether and quinine should await a systematic overview of many randomized, controlled trials. If this confirms that artemether treatment is associated with a lower mortality rate than quinine, and there is no associated increase in neurologic sequelae, then any effect on the duration of coma will have secondary importance. Dr. Newmark is correct; an error crept into the manuscript. The line should have read, “the correlated QT interval was prolonged to more than 0.5 second.”

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

[Response to inhaled granulocyte-macrophage colony-stimulating factor in a patient with alveolar proteinosis].

Pulmonary alveolar proteinosis is a rare disease characterized by the accumulation of lipoproteinaceous material derived from alveolar surfactant in the alveoli, with a consequent deterioration in gas exchange. Pathogenesis is related to impaired phagocytic function of alveolar macrophages. In recent years, a new treatment for pulmonary alveolar proteinosis-consisting of subcutaneous administra...

متن کامل

Deficit of osteoprotegerin release by osteoblasts from a patient with cystic fibrosis.

1 Rosen SH, Castleman B, Liebow AA. Pulmonary alveolar proteinosis. N Engl J Med 1958; 258: 1123–1142. 2 Kitamura T, Tanaka N, Watanabe J, et al. Idiopathic pulmonary alveolar proteinosis as an autoimmune disease with neutralizing antibody against granulocyte/macrophage colony-stimulating factor. J Exp Med 1999; 190: 875–880. 3 Seymour JF, Presneill JJ. Pulmonary alveolar proteinosis: progress ...

متن کامل

State of the Art

Description of a “New” Disease Nature of the Accumulated Alveolar Material Published Features of Patients with PAP Presentation Demographic Features Smoking Age Arterial Oxygen Pressure Serum LDH Spirometric and Radiographic Features Diagnostic Procedures Histopathology Pathogenesis and Classification Acquired PAP Congenital PAP Secondary PAP Development of Effective Treatment Application and E...

متن کامل

Potential association between membranous nephropathy and sargramostim therapy for pulmonary alveolar proteinosis

We present the case of a 43-year-old woman with a diagnosis of pulmonary alveolar proteinosis, on chronic treatment with sargramostim, a recombinant granulocyte-macrophage colony-stimulating factor, who presented with the nephrotic syndrome secondary to biopsy-proven membranous nephropathy. We discuss potential underlying mechanisms, including speculated effects of sargramostim on mesangial cel...

متن کامل

Pulmonary alveolar proteinosis in a cat.

BACKGROUND Pulmonary alveolar proteinosis is an extremely rare lung disease in animals and humans. It is characterized by the deposition of a large amount of phospholipoproteinaceous material in the alveoli. There are several possible etiologies, both congenital and acquired. Alveolar macrophages play an important role in the clearance of surfactant. This is the first report of pulmonary alveol...

متن کامل

Granulocyte macrophage colony stimulating factor therapy for pulmonary alveolar proteinosis.

We report a case of 58 year old female diagnosed with Pulmonary Alveolar Proteinosis (PAP) with recurrence of PAP after 5 repeated whole lung lavage, responding to subcutaneous injections of Granulocyte Macrophage Colony Stimulating Factor therapy (GM-CSF). Thus indicating that GM-CSF therapy is a promising alternative in those requiring repeated whole lung lavage

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:
  • The New England journal of medicine

دوره 335 25  شماره 

صفحات  -

تاریخ انتشار 1996